Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
bluebird bio, Inc. (BLUE)
Sector: Healthcare; Industry: Biotechnology

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer. The company's product candidates in oncology include bb2121 and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. The company also has collaborations with Medigene AG to discover T cell receptor (TCR) product candidates in the field of cancer; Gritstone Oncology, Inc. to discover TCR product candidates in the field of cancer; TC BioPharm Limited to research and develop gamma delta CAR T cells directed at hematologic and solid tumor targets; and Novo Nordisk A/S to develop in vivo genome editing treatments for genetic diseases. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-01-06 Leschly Nick President and CEO Sell 10,428 $45.05 $469,783 No
2021-01-06 Baird William D III Chief Financial Officer Sell 949 $45.05 $42,756 No
2021-01-06 FINGER ALISON CECILY Chief Commercial Officer Sell 1,854 $45.05 $83,525 No
2021-01-06 Davidson David Chief Medical Officer Sell 3,215 $45.05 $144,841 No
2021-01-06 Cole Jason Chief Operating and Sell 2,401 $45.05 $108,169 No
2021-01-06 Smith-Farrell Joanne COO, Oncology Sell 1,329 $45.05 $59,872 No
2021-01-06 Gregory Philip D Chief Scientific Officer Sell 2,799 $45.05 $126,100 No
2020-12-03 Burnett Katy Principal Accounting Officer Sell 123 $46.09 $5,669 No
2020-12-02 FINGER ALISON CECILY Chief Commercial Officer Sell 36 $46.20 $1,663 No
2020-12-02 Smith-Farrell Joanne COO, Oncology Sell 38 $46.20 $1,756 No
2020-12-02 Cole Jason Chief Operating and Sell 38 $46.20 $1,756 No
2020-12-02 Gregory Philip D Chief Scientific Officer Sell 59 $46.20 $2,726 No
2020-12-02 Davidson David Chief Medical Officer Sell 64 $46.20 $2,957 No
2020-12-02 Leschly Nick President and CEO Sell 444 $46.20 $20,512 No
2020-11-02 FINGER ALISON CECILY Chief Commercial Officer Sell 35 $52.99 $1,855 No
2020-11-02 Smith-Farrell Joanne COO, Oncology Sell 37 $52.97 $1,960 No
2020-11-02 Cole Jason Chief Operating and Sell 37 $52.97 $1,960 No
2020-11-02 Gregory Philip D Chief Scientific Officer Sell 59 $52.93 $3,123 No
2020-11-02 Davidson David Chief Medical Officer Sell 63 $52.94 $3,335 No
2020-11-02 Leschly Nick President and CEO Sell 444 $52.94 $23,506 No
2020-10-02 Davidson David Chief Medical Officer Sell 64 $52.77 $3,377 No
2020-10-02 Cole Jason Chief Operating and Sell 38 $52.77 $2,005 No
2020-10-02 Smith-Farrell Joanne Chief Business Officer Sell 38 $52.77 $2,005 No
2020-10-02 FINGER ALISON CECILY Chief Commercial Officer Sell 36 $52.77 $1,900 No
2020-10-02 Leschly Nick President and CEO Sell 450 $52.77 $23,744 No
2020-10-02 Gregory Philip D Chief Scientific Officer Sell 60 $52.77 $3,166 No
2020-09-03 FINGER ALISON CECILY Chief Commercial Officer Sell 35 $58.60 $2,051 No
2020-09-03 Smith-Farrell Joanne Chief Business Officer Sell 36 $58.60 $2,110 No
2020-09-03 Cole Jason Chief Operating and Sell 36 $58.60 $2,110 No
2020-09-03 Gregory Philip D Chief Scientific Officer Sell 58 $58.60 $3,399 No

Insider Smart

PENN NATIONAL GAMING INC (PENN) - PENN took a deep dive from $36 to $5 due to the crash, anyone who was bold enough to pick up some shares in March or April could have made a 900% profit in 2 months. But bottom fishing is always easier said than done, if one took a safer bet and followed multiple insider buying around $18, a 100% profit is still impressive.

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!